Medtronic wins FDA clearance, CE Mark for cardiac mapping software
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/21/2026
- Nasdaq leads Wall Street gains as SpaceX, Super Micro boost AI sentiment
- SpaceX, Tesla shares rise after Musk says committees exploring possible merger
- Brent falls as Iran's president discusses mediation with Pakistani army chief
- Nvidia’s Huang highlights AI benefits in Berlin speech amid wider European tour
- AI bubble about to burst? Not yet, Yardeni says
- Abbott plans to spin off its nutrition unit as a standalone public company
- Alphabet shares drop ahead of earnings next week
- Supermicro raises Q1 FY2027 revenue outlook on AI demand
- Dow outperforms as Wall Street rises, healthcare stocks lead gains
- Crude Inventory Fell 3.06 Million Barrels Last Week - EIA
Medtronic announces regulatory milestones for newest cardiac mapping and ablation software
September 30, 2026 9:01 AM EDTFDA clearance and CE Mark for latest Affera Prism-2 Mapping Software expand cardiac mapping capabilities
CE Mark for PulseSelect ProxBox Adapter with Proximity Indicator software adds real-time tissue proximity feedback
GALWAY, Ireland, Sept. 30, 2026 /PRNewswire/ -- Medtronic (NYSE: MDT), a global leader in healthcare technology, today announced regulatory milestones for software used with two cardiac ablation... More



